Navigation Links
New Edition of Guidelines for Involving Communities in HIV Prevention Research Released at International AIDS Conference
Date:7/23/2010

GPP Plays Critical Role in Moving HIV Prevention Research Agenda Forward

VIENNA, July 23 /PRNewswire-USNewswire/ -- The draft second edition of The Good Participatory Practice (GPP) Guidelines for Biomedical HIV Prevention Trials were released yesterday at the International AIDS Conference in Vienna by AVAC. The GPP Guidelines aim to provide trial funders, sponsors, and implementers with systematic guidance on how to effectively work with a range of stakeholders as they design and conduct biomedical HIV prevention trials.

The guidelines were developed by AVAC and UNAIDS in consultation with a broad range of global stakeholders who have provided perspectives since the first edition was published in 2007. AVAC and UNAIDS are now seeking feedback on the draft second edition from those with interest and expertise in HIV prevention research until 31 October, after which the final second edition will be published.

Clinical trials are guided by Good Clinical Practice, Good Laboratory Practice, and other guidelines and regulations that cover scientific and general ethical conduct, but global guidelines had not existed for community engagement before the first publication of GPP.

"Recent breakthroughs, including positive results from the CAPRISA 004 microbicide trial, have reenergized prevention research, and around the world, thousands of research participants and hundreds of researchers and trial site staff are working together find new HIV prevention options. Thousands more will be needed as we work to find new solutions to ending the AIDS epidemic," said Mitchell Warren, executive director of AVAC.

"The GPP Guidelines were developed to fill an important gap in the conduct of biomedical HIV prevention research and to help research teams, trial sponsors, trial funders, communities, advocates, and other stakeholders plan, implement, and evaluate community engagement in trials, reduce unnecessary conflict and ensure that research is meaningful to both communities and trial implementers," Warren added.

"AVAC and UNAIDS is pleased to release this new version of the GPP guidelines at the conference at which the groundbreaking results of the CAPRISA tenofovir microbicide gel trial have been presented, recalling that it was the stopping of antiretroviral pre-exposure prophylaxis trials in 2004 that first inspired the development of the GPP guidelines," said Dr. Catherine Hankins, UNAIDS' chief scientific adviser.

The GPP guidelines include:

  • Guiding Principles of GPP that serve as the foundation of the relationship between trial funders, sponsors, implementers, and other stakeholders.

  • GPP Standards that trial funders, sponsors, and implementers should follow when designing, preparing for, conducting, and concluding a biomedical HIV prevention trial.

The GPP Guidelines are available online at: www.avac.org/gppdocuments or www.unaids.org.


'/>"/>
SOURCE AVAC; UNAIDS
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition]
2. Ranexa(R) Added to New ACC/AHA Guidelines on Unstable Angina/Non ST-Elevation Myocardial Infarction (UA/NSTEMI)
3. DHHS Guidelines Support Use of Trofile(TM) Assay Prior to CCR5 Inhibitor Use
4. New Guidelines: Antibiotic Prophylaxis
5. ACR Supports American Cancer Society Inclusion of CT Colonography (Virtual Colonoscopy) as Recommended Screening Tool for Colorectal Cancer in New Screening Guidelines
6. Lung Cancer Alliance Commends NCCN on Screening Guidelines
7. Published Guidelines Further Support Use of Bioimpedance Measurement Technology for Early Assessment of Lymphedema
8. Thrombosis Guidelines Emphasize Difficult Choices for Pregnant Women
9. Agendias MammaPrint(R) Included in 2008 Dutch Institute for Healthcare Improvement CBO Guidelines
10. NCCN Updates NHL Guidelines Following FDA Approval of Pralatrexate
11. Cancer Treatment Guidelines for Diverse Asian Economies Use Model Developed at Fred Hutchinson Cancer Research Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... CITY, Calif. , Jan. 19, 2017  Abaxis, ... company manufacturing point-of-care blood analysis instruments and consumables for ... conference call to discuss its financial results for the ... The call will be at 4:15 p.m. ET on ... results for the third quarter fiscal year 2017 after ...
(Date:1/19/2017)... , Jan. 19, 2017  Sensus Healthcare, Inc. ... company specializing in the treatment of non-melanoma skin ... with superficial radiation therapy, today announced that it ... 2016 financial results on Thursday, February 2, 2017 after ... hold a conference call with the investment community ...
(Date:1/19/2017)... LEXINGTON, Massachusetts , January 19, 2017 ... SHPG ) announced that the U.S. Food and Drug ... resubmission of a New Drug Application (NDA) for SHP465, ... being evaluated as a potential once-daily treatment for Attention-Deficit/Hyperactivity ... decision on or around June 20, 2017, the designated ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... ... A new partnership between Goodwill® and Roadie, Inc. aims to make it easier ... couches to dressers and bicycles. Roadie — the national on-the-way delivery network — will ... through February 28th. , “January is an exciting time when resolutions are made ...
(Date:1/20/2017)... FL (PRWEB) , ... January 20, 2017 , ... Source ... botanicals and 100 percent pure essential oils, announced the company had a successful visit ... , The annual ECRM event gives companies that work in the nutritional, sports and ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Bionic Sports ... all walks of life, announced it had a successful January ECRM Trade Show in ... in the United States, which allows it to provide its products to all clients ...
(Date:1/20/2017)... ... January 20, 2017 , ... ATP Science, an Australian-based company ... attended the January ECRM Trade Show in Hilton Head, SC, benefiting from outstanding ... range of supplements that keep the body functioning at its peak performance by ...
(Date:1/20/2017)... boca raton florida (PRWEB) , ... January 20, 2017 , ... ... trial at the Dana Farber Cancer Institute. For Betsy, the clinical trial has ... and her cancer has not worsened. , Betsy Brauser was diagnosed with ovarian ...
Breaking Medicine News(10 mins):